Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
A Phase II, Multicenter, Open-Label, Randomized Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
A Phase II, Multicenter, Open-Label, Randomized Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
A Phase II, Multicenter, Open-Label, Randomized Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
A Phase II, Multicenter, Open-Label, Randomized Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
A Phase II, Multicenter, Open-Label, Randomized Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Status: Archived
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
A Phase II, Multicenter, Open-Label, Randomized Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers
Support for Hispanic Breast Cancer Patients and Caregivers
Status: Archived
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers
Support for Hispanic Breast Cancer Patients and Caregivers
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
Magnetic Resonance Imaging of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Anthracycline-based Systemic Chemotherapy
Status: Archived
Medical Oncology Hematology Associates, Inc
mi
from
Dayton, OH
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
Magnetic Resonance Imaging of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Anthracycline-based Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Medical Oncology Hematology Associates, Inc
mi
from
Dayton, OH
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
Magnetic Resonance Imaging of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Anthracycline-based Systemic Chemotherapy
Status: Archived
Innovation Center, Kettering Health Network
mi
from
Kettering, OH
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
Magnetic Resonance Imaging of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Anthracycline-based Systemic Chemotherapy
Status: Archived
Updated: 1/1/1970
Innovation Center, Kettering Health Network
mi
from
Kettering, OH
Health SMART (Stress Management and Relaxation Training)
Phase II Study of Stress Management and Vaccine Response Among Women at Risk for Breast Cancer
Status: Archived
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Health SMART (Stress Management and Relaxation Training)
Phase II Study of Stress Management and Vaccine Response Among Women at Risk for Breast Cancer
Status: Archived
Updated: 1/1/1970
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
X-Ray Mammography Standard of Care Protocol
X-Ray Mammography Standard of Care Protocol
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
X-Ray Mammography Standard of Care Protocol
X-Ray Mammography Standard of Care Protocol
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Waterbury Hospital
mi
from
Waterbury, CT
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Updated: 1/1/1970
Waterbury Hospital
mi
from
Waterbury, CT
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Jackson Memorial Hospital
mi
from
Miami, FL
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Updated: 1/1/1970
Jackson Memorial Hospital
mi
from
Miami, FL
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
University of Iowa
mi
from
Iowa City, IA
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Tulane University Medical Center
mi
from
New Orleans, LA
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Updated: 1/1/1970
Tulane University Medical Center
mi
from
New Orleans, LA
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Henry Ford Hospital
mi
from
Detroit, MI
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Updated: 1/1/1970
Henry Ford Hospital
mi
from
Detroit, MI
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Xpress Digital Mammography System Images for Computer Aided Detection Development
A Multi-Center Clinical Study to Acquire Xpress Digital Mammography System Images for Computer Aided Detection Development
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Clinical Trial Facility
mi
from
Centralia, IL
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Centralia, IL
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Clinical Trial Facility
mi
from
Boston, MA
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Boston, MA
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
Sarah Cannon Cancer Center
mi
from
Nashville, TN
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
A Phase IA, Multicenter, Open-label Dose Escalation Study of BKM120, Administered Orally in Adult Patients With Advanced Solid Malignancies
Status: Archived
Updated: 1/1/1970
Sarah Cannon Cancer Center
mi
from
Nashville, TN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Hematology Oncology Associates
mi
from
Phoenix, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates
mi
from
Phoenix, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Northern Arizona Hematology & Oncology Associates
mi
from
Sedona, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Northern Arizona Hematology & Oncology Associates
mi
from
Sedona, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Arizona Oncology Associates - Rudasill
mi
from
Tucson, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Arizona Oncology Associates - Rudasill
mi
from
Tucson, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Southwest Cancer Care
mi
from
Escondido, CA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Southwest Cancer Care
mi
from
Escondido, CA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Rocky Mountain Cancer Center
mi
from
Denver, CO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Rocky Mountain Cancer Center
mi
from
Denver, CO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Florida Cancer Institute - New Hope
mi
from
Hudson, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Florida Cancer Institute - New Hope
mi
from
Hudson, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Melbourne Internal Medical Associates
mi
from
Melbourne, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Melbourne Internal Medical Associates
mi
from
Melbourne, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Florida Institute of Research, Medicine & Surgery
mi
from
Ocoee, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Florida Institute of Research, Medicine & Surgery
mi
from
Ocoee, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Cancer Care & Hematology Specialists of Chicagoland
mi
from
Niles, IL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Cancer Care & Hematology Specialists of Chicagoland
mi
from
Niles, IL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Central Indiana Cancer Centers
mi
from
Carmel, IN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Central Indiana Cancer Centers
mi
from
Carmel, IN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Alliance Hematology Oncology
mi
from
Westminister, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Alliance Hematology Oncology
mi
from
Westminister, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Minnesota Oncology Hematology, P.A.
mi
from
Minneapolis, MN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Minnesota Oncology Hematology, P.A.
mi
from
Minneapolis, MN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Missouri Cancer Associates
mi
from
Columbia, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Missouri Cancer Associates
mi
from
Columbia, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Maryland Oncology Hematology PA
mi
from
Columbia, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Maryland Oncology Hematology PA
mi
from
Columbia, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Kansas City Cancer Center, LLC
mi
from
Overland Park, KA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Kansas City Cancer Center, LLC
mi
from
Overland Park, KA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
St. Joseph Oncology, INC
mi
from
St. Joseph, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
St. Joseph Oncology, INC
mi
from
St. Joseph, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Comprehensive Cancer Care Centers of Nevada
mi
from
Henderson, NV
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Comprehensive Cancer Care Centers of Nevada
mi
from
Henderson, NV
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Ruth Oratz MD
mi
from
New York, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Ruth Oratz MD
mi
from
New York, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Interlakes Oncology/Hematology PC
mi
from
Rochester, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Interlakes Oncology/Hematology PC
mi
from
Rochester, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Dayton Clinical Research
mi
from
Dayton, OH
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Dayton Clinical Research
mi
from
Dayton, OH
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Northwest Cancer Specialists-134th St.
mi
from
Vancouver, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Northwest Cancer Specialists-134th St.
mi
from
Vancouver, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Medical Oncology Associates
mi
from
Kingston, PA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Medical Oncology Associates
mi
from
Kingston, PA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Texas Oncology Medical City Dallas
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology Medical City Dallas
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Texas Oncology-Abilene
mi
from
Abilene, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology-Abilene
mi
from
Abilene, TX